Medical Grand Rounds - "Optimizing HIV Outcomes in Challenging Scenarios"

Friday, September 30, 2022 | 12 p.m. - 1 p.m.
Microsoft Teams

Presenter: Eric S. Darr, MD, Chief, Division of HIV Medicine, Harbor-UCLA Medical Center; Professor of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California

At the conclusion of this activity, participants should be able to:

  1. Integrate best practices in the evidence-based management of ART across the spectrum of ART experience.
  2. Incorporate the latest data and expert insights on emerging innovative ARV treatment or prevention paradigms into the individualized care of persons with or at risk of HIV infection.
  3. Appropriately counsel patients regarding the anticipated clinical role of new and investigational ART regimens.

Date, Time & Location:

Friday, September 30, 2022 at 12:00 p.m.
Microsoft Teams - E-mail Trish.Stern@guthrie.org to be included

This program is intended for: Physicians, Advanced Practice Providers, Fellows, Residents, Medical and Nursing Students, and other Ancillary Healthcare Professionals.

Accreditation Statement
“The Guthrie Clinic is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.”
Designation Statement
“The Guthrie Clinic designates this live activity for a maximum of (1.0) AMA PRA Category I Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”
Disclosure Statement
“Faculty and all others who have the ability to control the content of continuing medical education activities provided by The Guthrie Clinic are expected to disclose to the audience whether they do or do not have any real or apparent relevant financial relationships related to this educational activity.” “The presenting faculty/planning committee for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”